Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Postgraduate Medicine|August 1, 1982
Hyperlipidemia therapy: can it prevent coronary atherosclerosis?D T NashJournal of Medicine|January 1, 1977
Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combinationD T NashArchives of Internal Medicine|May 2, 2000
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study GroupJ R Guyton, M A Blazing, J Hagar, et al.International Journal of Cardiology|January 1, 1982
Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriographyD T Nash, G Gensini, P EsenteJournal of Cardiovascular Pharmacology|January 1, 1988
Long-term efficacy and safety of nitrendipine in severe essential hypertensionJ F Burris, D T Nash, W J MroczekJournal of the American College of Nutrition|January 1, 1982
Effect of high-chromium brewer's yeast on human serum lipidsJ C Elwood, D T Nash, D H StreetenJournal of the American Geriatrics Society|June 1, 1978
Relationship of age and biomedical risk factors to progression of coronary artery diseaseJ P Abrahams, D T Nash, G G Gensini, et al.Journal of Community Health|January 1, 1989
Risk factor knowledge, status, and change in a community screening projectJ R Sutterer, M P Carey, D K Silver, et al.The American Journal of Cardiology|May 29, 1987
A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertensionD T Nash, G Schonfeld, R L Reeves, et al.Pageof 3